Capture of the human IgG1 antibodies by protein a for the kinetic study of h-IgG/FcγR interaction using SPR-based biosensor technology

Methods in Molecular Biology

Volumn 988, Issue , 2013, Pages 331-343

  Champion, Thierry ^a   Beck, Alain ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

ADCC; Biacore X100; Fcgamma receptor; IgG effector functions; Protein A capture; Surface plasmon resonance

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIIA; IMMUNOGLOBULIN G1 ANTIBODY; LIGAND; PROTEIN A; TRASTUZUMAB; UNCLASSIFIED DRUG; FCGR1A PROTEIN, HUMAN; FCGR3A PROTEIN, HUMAN; IMMOBILIZED PROTEIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; STAPHYLOCOCCUS PROTEIN A;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BIOSENSOR; HUMAN; IMMUNOGLOBULIN PURIFICATION; IN VITRO STUDY; KINETICS; PRIORITY JOURNAL; PROTEIN INTERACTION; PURIFICATION; SUPERNATANT; SURFACE PLASMON RESONANCE; CHEMISTRY; METHODOLOGY; PROTEIN BINDING; PROTEIN MICROARRAY;

ANTIBODIES, MONOCLONAL, HUMANIZED; HUMANS; IMMOBILIZED PROTEINS; IMMUNOGLOBULIN G; KINETICS; PROTEIN ARRAY ANALYSIS; PROTEIN BINDING; RECEPTORS, IGG; STAPHYLOCOCCAL PROTEIN A; SURFACE PLASMON RESONANCE;

EID: 84882999260     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-327-5_21     Document Type: Article

References (7)

1. Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47
2. Carton G, Watier H, Golay J, Solal-Celigny P (2004) From the bench to the bedside: ways to improve rituximab efficacy. Blood 104: 2635-2642
3. Jiang XR, Song A, Bergelson S, Arroll T, Parekh B, May K, Chung S, Strouse R, Mire-Sluis A, Schenerman M (2011) Advances in the assessment and control of the effector functions of therapeutic antibodies. Nat Rev Drug Discov 10: 101-110
4. Ferrara C, Grau S, Jäger C, Sondermann P, Brünker P, Waldhauer I, Hennig M, Ruf A, Rufer AC, Sthile M, Umaňa P, Benz J (2011) Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc g RIII and antibodies lacking core fucose. Proc Natl Acad Sci U S A 108: 12269-12674
5. Wang X, Das TK, Singh SK, Kumar S (2009) Potential aggregation prone regions in biotherapeutics: a survey of commercial antibodies. MAbs 1: 254-267
6. Sulica A, Medesan C, Laky M, Onicǎ; D, Sjöquist J, Ghetie V (1979) Effect of protein A of Staphylococcus aureus on the binding of monomeric and polymeric IgG to Fc receptorbearing cells. Immunology 38: 173-179
7. Juntilla TT, Parsons K, Olsson C, Lu Y, Xin Y, Theriault J, Crocker L, Pabonan O, Baginski T, Meng G, Totpal K, Kelley RF, Sliwkowski MX (2010) Superior in vivo efficacy of afucosylated Trastuzumab in the treatment of HER2-amplified breast cancer. Cancer Res 70: 4481-4489